Shelly M. Fujikawa, Ph.D.
Frommer Lawrence & Haug LLP
Author, FDA Lawyers Blog, www.fdalawyersblog.com
Dr. Fujikawa's practice focuses on the patent prosecution of biotechnology and chemical technologies in both domestic and foreign jurisdictions as well as freedom to operate and patentability opinions.
Frommer Lawrence & Haug LLP [Associate] 2010 - Present
Darby & Darby [Associate, Patent Agent, and Scientific Advisor] 2003 - 2010
B.S. Chemistry, Harvey Mudd College, 1998 (with high distinction)
Ph.D. Genetics, Harvard University, 2003
J.D., Fordham University School of Law, 2008
2005, Langmuir, "Shrink-wrap vesicles". Langmuir 21:12124-9 (2005).
2004, Bioorg. Med. Chem., "Synthesis and biological evaluation of disubstituted N6-cyclopentyladenine analogues: the search for a neutral antagonist with high affinity for the adenosine A1 receptor".
2003, Science, "Experimental models of primitive cellular components: encapsulation, growth, and division."
2002, J. Med. Chem., "5'-Deoxy congeners of 9-(3-amido-3-deoxy-b-D-xylofuranosyl)-N6-cyclopentyladenine: new adenosine A1 receptor antagonists and inverse agonists."
2002, Poster at Bioastronomy 2002: Life among the stars, Hamilton, Island, Australia, "Mineral-catalyzed formation of biological compounds."
2002, Bioastronomy 2002: Life among the stars, Hamilton Island, Australia, "First steps to engineering a protocell."